Stocktoria
Cryoport, Inc. CYRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-07-24
Cryoport, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $176.2M | $156.8M | $168.7M | $237.3M | $222.6M |
| Gross profit | $83.1M | $69.7M | $75.3M | $103.9M | $96.6M |
| R&D expense | $17.0M | $17.7M | $18.0M | $15.7M | $16.8M |
| SG&A expense | $102.8M | $109.8M | $108.3M | $120.1M | $97.6M |
| Operating income | -$36.8M | -$121.7M | -$100.5M | -$31.9M | -$17.8M |
| Interest expense | — | — | $5.5M | $6.1M | $4.7M |
| Income tax | $1.8M | $359,000 | $345,000 | $2.2M | $1.7M |
| Net income | $78.3M | -$114.8M | -$99.6M | -$37.3M | -$275.5M |
| EPS (diluted) | $1.40 | $-2.49 | $-2.21 | $-0.93 | $-6.18 |
| Operating cash flow | -$8.6M | -$16.3M | -$757,000 | -$1.9M | $8.1M |
| Free cash flow | -$25.0M | -$33.6M | -$39.5M | -$24.0M | -$15.8M |
| Cash & equivalents | $250.5M | $34.1M | $35.2M | $29.2M | $139.1M |
| Inventory | $23.2M | $21.5M | $26.2M | $27.7M | $16.5M |
| Total assets | $765.0M | $703.5M | $957.7M | $1.0B | $1.1B |
| Total liabilities | $262.4M | $301.6M | $468.7M | $482.9M | $471.1M |
| Shareholders' equity | $502.6M | $401.9M | $489.0M | $555.8M | $641.8M |
Source: SEC EDGAR filings · CIK 0001124524 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.